Search results
Showing 706 to 720 of 1094 results for infections
Comes from guidance Hepatitis B and C testing: people at risk of infection Number PH43 Date issued December 2012 Other
Comes from guidance Hepatitis B and C testing: people at risk of infection Number PH43 Date issued December 2012 Other
Comes from guidance Hepatitis B and C testing: people at risk of infection Number PH43 Date issued December 2012 Other
Comes from guidance Hepatitis B and C testing: people at risk of infection Number PH43 Date issued December 2012 Other
Curos for preventing infections when using needleless connectors (MTG44)
We have moved Medical technologies guidance 44 to become HealthTech guidance 510. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Comes from guidance Hepatitis B and C testing: people at risk of infection Number PH43 Date issued December 2012 Other
including: bleeding symptomatic and asymptomatic intracranial bleeding infection cannulation complications pain. Source guidance details
Evidence-based recommendations on percutaneous intradiscal radiofrequency treatment of the intervertebral disc nucleus for low back pain. This involves relieving low back pain by delivering heat energy to the damaged disc.
Source guidance details Comes from guidance Neonatal infection: antibiotics for prevention and treatment Number NG195
guidance details Comes from guidance Healthcare-associated infections: prevention and control in primary and community care Number
Faecal microbiota transplant for recurrent Clostridioides difficile infection (MTG71)
We have moved Medical technologies guidance 71 to become HealthTech guidance 638. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Faecal microbiota transplant for recurrent Clostridium difficile infection (IPG485)
We have moved interventional procedures guidance 485 to become HealthTech guidance 338. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
This guideline covers the assessment for and management of blood transfusions in adults, young people and children over 1 year old. It covers the general principles of blood transfusion, but does not make recommendations relating to specific conditions.
encephalopathy there is a clearly defined precipitating factor (for example, infections, gastrointestinal bleeding or overuse of...
Evidence-based recommendations on therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors (LISA-TRACKER, IDKmonitor and Promonitor ELISA kits) in people with Crohn’s disease.